[{"ATTACHMENTNAME":"b7ad2652-2dcf-4e00-ba4b-ef4b208fa7a7.pdf","NEWS_DT":"2022-11-22T17:20:20.56","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"This is further to our earlier letter dated November 15, 2022 regarding presentation and video recording of Q2 FY23 Earnings Call held on November 15, 2022, please find enclosed herewith the transcript of the Earnings Call. The same is also available on the website of the Company at https://www.biocon.com/investor-relations/financial-information/earning-call-transcripts/.\r\n\r\nKindly take the above said information on record.\r\n","SCRIP_CD":532523,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"d35e599d-92a2-407f-bc5d-2a85763377ae.pdf","NEWS_DT":"2022-08-03T19:29:23.957","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"This is further to our earlier letter dated July 28, 2022 regarding presentation and video recording\r\nof Q1 FY23 Earnings Call held on July 28, 2022, please find enclosed herewith the transcript of\r\nthe Earnings Call. The same is also available on the website of the Company at\r\nhttps://www.biocon.com/investor-relations/financial-information/earning-calltranscripts/#\r\n1599024728333-3499b540-46d3.","SCRIP_CD":532523,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"ccb42ced-c193-4745-ade0-eb0336e4a529.pdf","NEWS_DT":"2022-05-06T17:47:43.927","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"This is further to our earlier letter dated April 29, 2022 regarding presentation and video recording of Q4 and full year FY22 Earnings Call held on April 29, 2022, please find enclosed herewith the transcript of the Earnings Call. The same is also available on the website of the Company at https://www.biocon.com/investor-relations/financial-information/earning-call-transcripts/.","SCRIP_CD":532523,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"}]